Search results for "bronchial"

showing 10 items of 201 documents

Cellular network in airways inflammation and remodelling

2002

Chronic inflammation and airway remodelling are two key steps in asthma pathophysiology. The development of chronic airway inflammation depends upon the continuous recruitment of inflammatory cells from the bloodstream towards the bronchial mucosa and by their subsequent functional activation. The release of inflammatory mediators by activated cells contributes to the generation of a complex network which involves mobile inflammatory cells and structural cells such as epithelial cells, fibroblasts and myofibroblasts. This network is responsible for the amplification and persistence of the inflammatory process as well as for the development of a peculiar microenvironment which can directly m…

Pulmonary and Respiratory MedicineAdolescentCellInflammationmedicineHumansAirway RemodellingChildLungAsthmaInflammationbusiness.industryAirway inflammationBronchial mucosaInfantmedicine.diseasePathophysiologyAsthmarespiratory tract diseasesCell biologyAirway Obstructionmedicine.anatomical_structureInfant; Lung; Humans; Asthma; Child; Bronchial Hyperreactivity; Airway Obstruction; Adolescent; InflammationPediatrics Perinatology and Child HealthImmunologymedicine.symptomBronchial HyperreactivitybusinessMyofibroblastHuman
researchProduct

Effect throughout the day of inhaled fenoterol on the bronchial responsiveness to histamine in asthmatic patients.

1987

The effect throughout the day of inhaled fenoterol on the bronchial responsiveness to inhaled histamine was evaluated in 8 asthmatic patients. The airway response to increasing concentration of histamine aerosol was assessed by measurement of forced expiratory volume in one second (FEV1). The provocative dose of histamine needed to cause a 20% fall in starting FEV1 was calculated from the cumulative log dose response curves. Histamine challenges were performed in duplicate, on separate days, after premedication with placebo or fenoterol given by metered dose inhalers in the morning and in the afternoon. The mean starting FEV1 in the morning and in the afternoon did not change significantly …

Pulmonary and Respiratory MedicineAdultMaleAdolescentmedicine.drug_classHistamine AntagonistsBronchial Provocation Testschemistry.chemical_compoundBronchodilatorForced Expiratory VolumemedicineHumansCircadian rhythmFenoterolAsthmaFenoterolbusiness.industryRespiratory diseaserespiratory systemmedicine.diseaseAsthmarespiratory tract diseasesCircadian RhythmBronchodilatationchemistryAnesthesiaImmunologyFemalebusinessAirwayHistaminemedicine.drugRespiration; international review of thoracic diseases
researchProduct

Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals.

2000

Elevated serum immunoglobulin (Ig)E is the hallmark of atopy, and contributes to asthma and bronchial hyperresponsiveness in atopic individuals. In contrast, the significance of IgE in nonallergic subjects is less clear. The aim of the present study is to clarify a potential association of IgE and asthma in absence of clinical allergy. To this purpose 1,219 consecutive patients of a pulmonary practice were evaluated. Nonallergic patients were defined by negative skin prick test, history of atopy and specific IgE, 509 subjects (42%) were nonallergic. Among these, 80 patients (16%) had elevated total IgE levels (150 U x mL(-1)). Prevalence and severity of asthma in nonallergic subjects with I…

Pulmonary and Respiratory MedicineAdultMaleAllergyImmunoglobulin EStatistics NonparametricAtopyRadioallergosorbent TestRisk FactorsmedicineHumansAsthmaRetrospective StudiesSkin Testsbiologymedicine.diagnostic_testbusiness.industryRadioallergosorbent testRespiratory diseaseAllergensImmunoglobulin Emedicine.diseaseAsthmarespiratory tract diseasesRespiratory Function TestsBronchial hyperresponsivenessImmunologybiology.proteinRegression AnalysisFemaleAntibodybusinessThe European respiratory journal
researchProduct

Prevalence of nocturnal asthma in a general population sample: determinants and effect of aging.

2000

Nocturnal asthma (NA) is important because of clinical and prognostic implications. Previous data on prevalence may be overestimated, because they are derived from selected series. Observations on monitoring of peak expiratory flow in elderly asthmatics suggested that prevalence of NA may increase with age. This study was designed to estimate the prevalence of NA-related symptoms in a sample drawn from a general population and evaluate the role of aging. Subjects (1,100, mean age 41.9, SD 22.8 years) were randomly selected from the lists of seven general practitioners. A questionnaire on nighttime and morning NA-associated symptoms was used and frequency of occurrence was rated as never, so…

Pulmonary and Respiratory MedicineAdultMaleSampling StudiePediatricsmedicine.medical_specialtyAgingRandomizationLogistic ModelPopulation samplePopulationPeak Expiratory Flow RateSettore MED/10 - Malattie Dell'Apparato RespiratorioLogistic regressionSampling StudiesRandom AllocationRisk FactorsSurveys and QuestionnairesEpidemiologymedicinePrevalenceSurveys and QuestionnaireImmunology and AllergyHumanseducationSicilyAsthmaMorningeducation.field_of_studybusiness.industryRisk Factormedicine.diseaseAsthmaCircadian RhythmLogistic ModelsPediatrics Perinatology and Child HealthNocturnal asthmaFemaleBronchial HyperreactivitybusinessHumanThe Journal of asthma : official journal of the Association for the Care of Asthma
researchProduct

Effect of cilomilast (Ariflo) on TNF-α, IL-8, and GM-CSF release by airway cells of patients with COPD

2003

Background: Inflammation in chronic obstructive pulmonary disease (COPD) is characterised by increased neutrophilic infiltration of the airways. Cilomilast, a novel selective phosphodiesterase 4 inhibitor in clinical development for COPD treatment, exerts anti-inflammatory effects. The ability of cilomilast to inhibit the release of neutrophil chemoattractants such as tumour necrosis factor (TNF)-α, interleukin (IL)-8, and granulocyte-macrophage colony stimulating factor (GM-CSF) by bronchial epithelial cells and sputum cells isolated from 10 patients with COPD, 14 normal controls, and 10 smokers was investigated. Methods: Bronchial epithelial cells obtained by bronchial brushing and sputum…

Pulmonary and Respiratory MedicineAdultMaleSputum CytologyCyclohexanecarboxylic AcidsPhosphodiesterase Inhibitorsmedicine.medical_treatmentChronic Obstructive Pulmonary DiseaseCarboxylic AcidsCell CountEnzyme-Linked Immunosorbent AssayRespiratory MucosaBronchial brushingPulmonary Disease Chronic ObstructiveNitrilesmedicineHumansInterleukin 8Cells CulturedAgedbusiness.industryTumor Necrosis Factor-alphaCilomilastInterleukin-8SputumGranulocyte-Macrophage Colony-Stimulating FactorEpithelial CellsMiddle Agedrespiratory tract diseasesBronchodilator AgentsChemotaxis LeukocyteCytokineGranulocyte macrophage colony-stimulating factorImmunologySputumTumor necrosis factor alphaFemalemedicine.symptombusinessmedicine.drug
researchProduct

Effect of beclomethasone dipropionate on the bronchial responsiveness to propranolol in asthmatics.

1990

The effect of four weeks of treatment with beclomethasone dipropionate (BDP, 500 micrograms twice daily) on the bronchial responsiveness to propranolol was examined in 16 patients with mild asthma in a placebo-controlled, double-blind crossover study. Propranolol was inhaled in doubling concentrations and the results were expressed as the cumulative dose producing a 20 percent fall in FEV1 (PC20). After four weeks of treatment with BDP, the mean FEV1 increased from 82.0 percent predicted to 88.1 percent predicted. The difference was significant (p less than 0.001). Treatment with BDP did not significantly change the responsiveness to propranolol, the geometric mean PC20 being 3.17 mg/ml bef…

Pulmonary and Respiratory MedicineAdultMaleTime FactorsMild asthmaPropranololCritical Care and Intensive Care MedicineBronchial Provocation TestsRandom AllocationDouble-Blind MethodForced Expiratory VolumeAdministration InhalationmedicineAsthmatic patientHumansAsthmaBronchial SpasmCumulative dosebusiness.industryRespiratory diseaseBeclomethasonerespiratory systemmedicine.diseaseCrossover studyPropranololAsthmaAnesthesiaBronchoconstrictionFemalemedicine.symptomCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

Smoking and Obesity Increase Airway Hyperesponsiveness Risk In the Elderly

2015

Objective of our study was assessing whether smoking and obesity might affect airways hyperresponsiveness (AHR) differently in younger and older subjects and whether this influence might be due to their different impacts on baseline lung function values at different ages. Methods 3,903 consecutive adult subjects with normal lung function (1,920 males; mean age 35.1±16.2; median FEV1:97.3% of predicted [interquartile range (IQR):89.7-105.2] and FEV1/FVC:84.6% of predicted [IQR:79.8-89.2]), having performed a methacholine test, were considered. They were subdivided into three groups according to age (18-39, 40-64 and ≥65 years) and into different sub-groups according to body mass index (BMI) …

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAgingAdolescentVital CapacitySettore MED/10 - Malattie Dell'Apparato RespiratorioBronchial Provocation Tests03 medical and health sciencesFEV1/FVC ratioYoung Adult0302 clinical medicineInterquartile rangeRisk FactorsInternal medicineForced Expiratory VolumemedicineRespiratory HypersensitivityHumansObesityYoung adultMethacholine ChlorideAsthmaAgedRetrospective Studiesbusiness.industrySmoking030206 dentistryrespiratory systemMiddle Agedmedicine.diseaseObesityrespiratory tract diseases030228 respiratory systemPediatrics Perinatology and Child HealthPhysical therapyasthma agingMethacholineFemaleAirwaybusinessBody mass indexmedicine.drug
researchProduct

Effect of age upon airway obstruction and reversibility in adult patients with asthma.

1998

In a cross-sectional study we evaluated the effect of aging (separately from that of duration of disease) on airway obstruction and reversibility by comparing two groups of non-smoker patients with asthma.We compared two groups of patients: group A, which had 50 subjects (8 men and 42 women) aged 59.7+/-4.6 years (mean +/- SD), and group B, comprised of 51 subjects (19 men and 32 women) who were 35.7+/-7.4 years old. The groups were selected because of comparable baseline degree of obstruction (FEV1 % of predicted, 67.8+/-20.3 in group A; 73.0+/-19.6 in group B, NS) and duration of the disease (14.0+/-11.7 years vs 11.2+/-9.1, NS). Spirometric examination, with a bronchodilator test, was pe…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAgingmedicine.drug_classVital CapacityDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioCritical Care and Intensive Care MedicineGroup AGroup BBronchial Provocation TestsBronchodilatorForced Expiratory VolumemedicineHumansAsthmaAgedbusiness.industryRespiratory diseaseAirway obstructionMiddle Agedmedicine.diseaseAsthmaSurgeryAirway ObstructionBronchial Provocation TestAgeingSpirometryAnesthesiaRespiratory MechanicsFemaleCardiology and Cardiovascular MedicinebusinessHumanChest
researchProduct

Modifications of airway responsiveness to adenosine 5'-monophosphate and exhaled nitric oxide concentrations after the pollen season in subjects with…

2002

s: To determine the effect of cessation of exposure to pollen on airway responsiveness to adenosine 5'-monophosphate (AMP) in subjects with pollen-induced rhinitis, and to explore the relationship between changes in airway responsiveness and changes in exhaled nitric oxide (ENO) levels.Subjects were studied during the pollen season and out of season.Specialist allergy unit in a university hospital.Fourteen subjects without asthma with pollen-induced rhinitis who showed bronchoconstriction in response to methacholine and AMP during the pollen season and 10 healthy nonatopic control subjects.In subjects with pollen-induced rhinitis, ENO concentrations, provocative concentration of agonist cau…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAllergyBronchoconstrictionCritical Care and Intensive Care Medicinemedicine.disease_causeNitric OxideBronchial Provocation TestsNitric oxideCohort Studieschemistry.chemical_compoundInternal medicinePollenForced Expiratory Volumeotorhinolaryngologic diseasesmedicineHumansExpirationMethacholine ChlorideAsthmabusiness.industryfood and beveragesRhinitis Allergic Seasonalrespiratory systemmedicine.diseaseAdenosine Monophosphaterespiratory tract diseasesEndocrinologychemistryBreath TestsSpirometryImmunologyExhaled nitric oxidePollenMethacholineBronchoconstrictionFemalemedicine.symptomBronchial HyperreactivityCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

Airway distensibility by HRCT in asthmatics and COPD with comparable airway obstruction.

2013

Introduction: Decreased airway distensibility (AD) in response to deep inspirations, as assessed by HRCT, has been associated with the severity of asthma and COPD. Aims: The current study was designed to compare the magnitude of AD by HRCT in individuals with asthma and COPD with comparable degrees of bronchial obstruction, and to explore factors that may influence it. Results: We enrolled a total of 12 asthmatics (M/F:7/5) and 8 COPD (7/1) with comparable degree of bronchial obstruction (FEV1% predicted mean±SEM: 69.1 ± 5.2% and 61.2 ± 5.0%, respectively; p = 0.31). Each subject underwent chest HRCT at FRC and at TLC. A total of 701 airways (range 20 to 38 airway per subject; 2.0 to 23.1 m…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyVital CapacityLung Volume MeasurementSettore MED/10 - Malattie Dell'Apparato RespiratorioImagingDeep inspirationPulmonary Disease Chronic ObstructiveInternal medicineForced Expiratory VolumeMultidetector Computed TomographyMedicineHumansLung volumesBronchial obstructionLungAsthmaAgedCOPDbusiness.industryrespiratory systemAirway obstructionMiddle Agedmedicine.diseaseAsthmarespiratory tract diseasesLung volumeAirway distensibility Asthma COPDSpirometryCardiologyFemaleRadiologyAirwaybusinessLung Volume MeasurementsHumanCOPD
researchProduct